Event chart MAYNE PHARMA GROUP LIMITED |
|
|
Upcoming events on MAYNE PHARMA GROUP LIMITED |
|
08/25/22 | | FY 2022 Earnings Release (Projected) |
02/24/23 | | Interim 2023 Earnings Release (Projected) |
08/25/23 | | FY 2023 Earnings Release (Projected) |
02/23/24 | | Interim 2024 Earnings Release (Projected) |
|
Past events on MAYNE PHARMA GROUP LIMITED |
|
02/24/22 | 05:30pm | | Interim 2022 Earnings Call |
02/24/22 | 04:09pm | | Interim 2022 Earnings Release |
11/22/21 | 05:00pm | | Annual General Meeting |
08/26/21 | 07:00pm | | FY 2021 Earnings Call |
08/26/21 | 06:09pm | | FY 2021 Earnings Release |
02/24/21 | | Interim 2021 Earnings Release |
02/23/21 | 05:00pm | | Interim 2021 Earnings Call |
11/23/20 | 06:00pm | | Annual General Meeting |
08/20/20 | 07:00pm | | FY 2020 Earnings Call |
08/20/20 | 06:16pm | | FY 2020 Earnings Release |
|
Past dividends on MAYNE PHARMA GROUP LIMITED |
|
- No events available -
|
|
Fiscal Period : June | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
Sales M AUD |
Released Forecast Spread | 573 597 -4,0% | 530 532 -0,33% | 525 525 -0,04% | 457 455 0,42% | 401 416 -3,6% | 403 |
Operating income (EBITDA) M AUD |
Released Forecast Spread | 207 217 -5,0% | 165 145 14% | 131 135 -2,8% | 95,3 87,8 8,6% | 63,5 67,4 -5,8% | 40,4 |
Operating profit (EBIT) M AUD |
Released Forecast Spread | 133 151 -12% | 86,2 74,3 16% | 37,2 43,3 -14% | 11,7 12,8 -8,9% | -3,70 -15,3 76% | -56,6 |
Pre-Tax Profit (EBT) M AUD |
Released Forecast Spread | 116 138 -16% | -167 -57,3 -191% | -354 27,0 -1 410% | -135 -37,5 -261% | -264 -258 -2,2% | -109 |
Net income M AUD |
Released Forecast Spread | 88,6 100 -12% | -134 -153 12% | -281 11,2 -2 599% | -92,8 -33,3 -178% | -208 -173 -21% | -75,3 |
EPS AUD |
Released Forecast Spread | 0,06 0,07 -9,0% | -0,09 -0,10 5,9% | -0,19 0,01 -2 332% | -0,06 -0,01 -327% | -0,13 -0,09 -41% | -0,05 | Announcement Date | 08/24/2017 | 08/23/2018 | 08/22/2019 | 08/20/2020 | 08/26/2021 | - |
|
|
Fiscal Period : June | 2018 S1 | 2018 S2 | 2019 S1 | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 |
Sales M AUD |
Released Forecast Spread | 243 239 1,9% | 287 284 1,1% | 274 281 -2,2% | 251 253 -0,89% | 227 237 -4,0% | 230 221 3,9% | 209 209 0,10% | 192 205 -6,5% | 196 205 -4,6% | 193 |
Operating income (EBITDA) M AUD |
Released Forecast Spread | 70,2 61,2 15% | 95,1 79,8 19% | 81,2 87,9 -7,6% | 49,7 52,0 -4,3% | 47,4 40,6 17% | 47,9 40,1 19% | 39,9 44,9 -11% | 23,6 23,0 2,6% | 23,7 23,4 1,5% | 11,7 |
Operating profit (EBIT) M AUD |
Released Forecast Spread | 29,6 23,0 29% | 56,6 33,2 70% | 19,6 42,7 -54% | 0,50 7,05 -93% | -12,3 3,00 -510% | 24,0 4,80 400% | 2,30 2,75 -16% | -6,00 -16,9 64% | -17,6 -12,2 -45% | -49,1 |
Pre-Tax Profit (EBT) M AUD |
Released Forecast Spread | -211 -11,9 -1 672% | 44,1 29,2 51% | 11,9 35,9 -67% | -366 -1,40 -26 014% | -25,0 -4,35 -474% | -110 -13,5 -718% | -229 -12,3 -1 771% | -34,6 -27,1 -28% | -63,7 -21,1 -202% | -45,1 |
Net income M AUD |
Released Forecast Spread | -174 -8,95 -1 846% | 40,2 21,3 89% | 2,60 26,1 -90% | -283 -4,60 -6 062% | -17,5 -3,25 -438% | -75,3 -14,0 -440% | -181 -8,70 -1 984% | -27,1 -18,7 -45% | -50,4 -14,8 -241% | -45,1 |
EPS
|
Released Forecast Spread | -0,12 -0,01 -1 952% | 0,03
| 0,00 0,02 -89% | -0,19 -0,00 -27 386% | -0,01 -0,00 -173% |
| -0,12 -0,01 -1 511% | -0,02 -0,01 -43% | -0,03 -0,01 -248% |
| Announcement Date | 02/22/2018 | 08/23/2018 | 02/21/2019 | 08/22/2019 | 02/20/2020 | 08/20/2020 | 02/23/2021 | 08/26/2021 | 02/24/2022 | - | |
|
|
Upcoming sector events for MAYNE PHARMA GROUP LIMITED |
|
|
|
Past sector events for MAYNE PHARMA GROUP LIMITED |
|
|
|
|
|
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|